Back to top

Image: Bigstock

New Strong Buy Stocks for December 21st

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

AutoNation, Inc. (AN - Free Report) : This automotive retailer in the United States has seen the Zacks Consensus Estimate for its current year earnings increasing 19.4% over the last 60 days.

AutoNation, Inc. Price and Consensus

Rio Tinto Group (RIO - Free Report) : This company that is engaged in finding, mining, and processing mineral resources across the world has seen the Zacks Consensus Estimate for its current year earnings increasing 4.1% over the last 60 days.

Rio Tinto PLC Price and Consensus

Wabash National Corporation (WNC - Free Report) : This designer, manufacturer and distributer of transportation and various industrial products has seen the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Wabash National Corporation Price and Consensus

American Axle & Manufacturing Holdings, Inc. (AXL - Free Report) : This designer and manufacturer of driveline and metal forming products has seen the Zacks Consensus Estimate for its current year earnings increasing 92.6% over the last 60 days.

American Axle & Manufacturing Holdings, Inc. Price and Consensus

Cantel Medical Corp. (CMD - Free Report) : This provider of infection prevention and control products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 58.5% over the last 60 days.

Cantel Medical Corp. Price and Consensus

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>